Drug Chatter -- Tracking biopharma stock chatter

💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch

Profile for Biogen Inc. (BIIB)

« Back to company index

BIIB Chatter Timeline

Stock Ticker for BIIB

Most Active Tweeters for BIIB

UserTweets
@Beeken_health 19
@TradingSin21 14
@StckPro 8
@Gambiste1 7
@newsfilterio 6

Recent Tweets for BIIB

newsfilterio @newsfilterio
$BIIB Eisai Limited and partner Biogen Inc presented detailed data from the positive Phase 3 CLARITY-AD study of le… https://t.co/fBkG1cpr9i
3:12am
modestus1 @modestus1
If the drug does get FDA accelerated approval, $BIIB could soar to $400+/share, as there has not been a new Alzheim… https://t.co/UeLQwJ3Oqk
3:12am
MAHEAG1 @MAHEAG1
$biib Top analyst price target for next week:~ https://t.co/fQ9VLksJPL
3:12am
biomed_stocks @biomed_stocks
#Biogen stock up 3% premarket after update on Alzheimer’s treatment. $BIIB
2:12am
TANSEN22212361 @TANSEN22212361
$biib Top analyst price target for next week:~ https://t.co/cK9SaMWl1u
2:12am
AlexHarding7 @AlexHarding7
RT @AndyBiotech: $BIIB My thought on lecanemab "clinical meaningfulness" debate: 18-mo rx slowed disease progression by 6~8mo. Is it not m…
1:12am
aboutheoptions @aboutheoptions
$BIIB Biogen (BIIB) and Eisai presents full results of Lecanemab Phase 3 confirmatory clarity ad study for early Al… https://t.co/zCkYXfQqaT
1:12am
newsfilterio @newsfilterio
Roche shutters most trials of Alzheimer's drug after failed trials $BIIB https://t.co/ckunfRW8Bv
12:12am
trystocknews @trystocknews
$BIIB Roche shutters most trials of Alzheimer's drug after failed trials
12:12am
UsMarketNews @UsMarketNews
$BIIB news Roche shutters most trials of Alzheimer's drug after failed trials
12:12am
Kevin_M_Biotech @Kevin_M_Biotech
@Sports_bios Approval will allow you to detail the product to physicians and contract so still very helpful! $biib
12:12am
drfranktarazi @drfranktarazi
$LLY #Donanemab produced significantly higher clearance of #amyloid plaques compared with $BIIB #Aduhelm in… https://t.co/fyWWZvrP3L
November 30th 2022, 11:11pm
sideline_floats @sideline_floats
Really screwed up the $Biib trade today. Oh well just a few scrapes and on to the next
November 30th 2022, 11:11pm
JacobPlieth @JacobPlieth
$LLY Trailblazer-Alz4 amyloid clearance was 38% for donanemab vs 2% for $BIIB Aduhelm. Aria-E ~20% (3-4% symptomati… https://t.co/w01OPUse6i
November 30th 2022, 11:11pm
optioncharts @optioncharts
$BIIB open interest for maturity 12/02/2022. High put=270.00 High call=345.00 PutCallRatio=1.27 #maxpain #options… https://t.co/9LRluyWtz7
November 30th 2022, 9:11pm
dailycandlestix @dailycandlestix
$BIIB Above Avg Volume Daily appearances since 2010: 162 Close 5 days later ±: Avg: -2.70 SD: 16.48 Worst: -111.37… https://t.co/icXIoPKexb
November 30th 2022, 9:11pm
TargetPrices @TargetPrices
$BIIB latest ratings on 2022-11-30 at Stock Target Advisor https://t.co/HfNbUOKZaG : Jefferies Financial LLC (Main… https://t.co/ASdlLJqn8n
November 30th 2022, 9:11pm
Chandan31667092 @Chandan31667092
RT @CNBCClosingBell: Eisai US CEO Ivan Cheung on the company's partnership with Biogen for the Alzheimer's drug Lecanemab $BIIB https://t.c…
November 30th 2022, 9:11pm
CNBCClosingBell @CNBCClosingBell
Eisai US CEO Ivan Cheung on the company's partnership with Biogen for the Alzheimer's drug Lecanemab $BIIB https://t.co/XOrq9k3NHB
November 30th 2022, 9:11pm
Beeken_health @Beeken_health
$BIIB $ESALY - 5 things to know about the new Alzheimer's drug — including why it may be risky for people who take… https://t.co/aLx7S0fumb
November 30th 2022, 9:11pm
Beeken_health @Beeken_health
$BIIB $ESALY - 5 things to know about the new Alzheimer's drug — including why it may be risky for people who take… https://t.co/WItqnHs5vj
November 30th 2022, 8:11pm
TradeForMeApp @TradeForMeApp
Trade For Me App - 03:38:10 - 14 period RSI crossed above 30 on the 1 min chart for $BIIB. #DayTrading #DayTrader… https://t.co/sMi2MCG2Yg
November 30th 2022, 8:11pm
RRli18 @RRli18
#Business #LifeSciences #Neutral $ESALF $BIIB 2022/12/01 05:19 Eisai, Biogen Alzheimer's drug could be available… https://t.co/bwEIAaRz5c
November 30th 2022, 8:11pm
chippy_ca @chippy_ca
RT @newsfilterio: Eisai, Biogen Alzheimer's drug could be available to some next year $BIIB $CMS https://t.co/zP1H4cK3GT
November 30th 2022, 8:11pm
Beeken_health @Beeken_health
$BIIB $ESALY - 5 things to know about the new Alzheimer's drug — including why it may be risky for people who take… https://t.co/nPf5syyOvH
November 30th 2022, 8:11pm
govermentchild @govermentchild
$biib funny how soon everyone forgot about the patient who died from a brain bleed . Also funny how that came out… https://t.co/yhGbe5aWVY
November 30th 2022, 8:11pm
newsfilterio @newsfilterio
Eisai, Biogen Alzheimer's drug could be available to some next year $BIIB $CMS https://t.co/zP1H4cK3GT
November 30th 2022, 8:11pm
Johan74691596 @Johan74691596
$biib Top analyst price target for next week: ~ https://t.co/SxTPNOCJpM
November 30th 2022, 7:11pm
dhovekamp42 @dhovekamp42
RT @JacobPlieth: If you're following #CTAD22 developments tonight there's: 3pm PT - Trailblazer-Alz 4, donanemab vs $BIIB Aduhelm, said by…
November 30th 2022, 7:11pm
ST8838599334 @ST8838599334
$BIIB long 303.36 avg exits 304.28 out 304.85 $CRWD short 112.05 covered 111.36 111.16 OUT 1112.32
November 30th 2022, 7:11pm
JoinStockCast @JoinStockCast
? Experimental drug Lecanemab may be a landmark breakthrough in battle against Alzheimer's https://t.co/z3tklg5Urb $BIIB $ESALY
November 30th 2022, 6:11pm
TradeForMeApp @TradeForMeApp
Trade For Me App - 01:41:09 - SMA10 crossed above SMA20 on the 5 min chart for $BIIB. #DayTrading #DayTrader… https://t.co/r8Tv5EVsPB
November 30th 2022, 6:11pm
update8145 @update8145
$biib Top analyst price target for next week:~' https://t.co/wSK29zjOSv...
November 30th 2022, 6:11pm
GCompounder @GCompounder
$BIIB anticipates FDA application verdict by 1/6/23 &, based on new late-stage trial results, & plans to seek full approval late in ‘23.
November 30th 2022, 6:11pm
bthefirsttoknow @bthefirsttoknow
First out// $BIIB: Despite Safety Concerns, Analysts Are Bullish On Biogen's Second Alzheimer's Candidate https://t.co/WFHjaYf0Cv
November 30th 2022, 6:11pm
govermentchild @govermentchild
$biib people fading the stock . Don’t like price action .
November 30th 2022, 5:11pm
TANSEN22212361 @TANSEN22212361
$biib Top analyst price target for next week:~ https://t.co/KGMlaOqKQ0
November 30th 2022, 5:11pm
WallStreetOdds @WallStreetOdds
Out of the 36 other times $BIIB was up 3.4% during a trading day, 64% of the time it traded lower by the same day's… https://t.co/YG5Bi1x50Q
November 30th 2022, 5:11pm
hb_cell @hb_cell
RT @IBD_AGatlin: $BIIB and $ESALY offered an update for their Alzheimer's drug, lecanemab. It led to a 24%-37% benefit on secondary measure…
November 30th 2022, 5:11pm
pramosferrer @pramosferrer
Exciting results from the full data report from $BIIB @biogen & @EisaiUS Lecanemab study. mAb approach is promising… https://t.co/MoJC84I1nG
November 30th 2022, 4:11am
Hall8Jack @Hall8Jack
RT @JacobPlieth: Clarity-AD: $ESALY lecanemab looks no different on efficacy vs $BIIB's cherrypicked Aduhelm data in Emerge, with less Aria…
November 30th 2022, 4:11am
YuZhu4 @YuZhu4
RT @zeusPharma: $BIIB Lecanemab results in NEJM. Initial impressions: 1. Treatment starts EARLY (ave MMSE of 26!). 2. Responses are quick a…
November 30th 2022, 3:11am
Hall8Jack @Hall8Jack
RT @AndyBiotech: $BIIB/Eisai - money slide for Lecanemab at #CTAD22 https://t.co/ZU1jjCYhyE The biggest promise of "disease modifying" (vs…
November 30th 2022, 3:11am
drbuffett @drbuffett
$biib and $prta should rally tomorrow
November 30th 2022, 3:11am
ManseSin @ManseSin
$biib Top analyst price target for next week:~ https://t.co/PhGVtDDuVz
November 30th 2022, 3:11am
AlexHarding7 @AlexHarding7
RT @adamfeuerstein: Here are some of the charts from the lecanemab CLARITY-AD study, published tonight in NEJM. $BIIB $ESALY The efficacy…
November 30th 2022, 3:11am
fwpharma @fwpharma
Safety looms large in full data reveal for Alzheimer's hopeful lecanemab $ESALY $BIIB https://t.co/YGFNzKVhNA
November 30th 2022, 3:11am
newsfilterio @newsfilterio
UPDATE 1-Alzheimer's drug from Eisai and Biogen slows cognitive decline, side-effects in focus $BIIB https://t.co/Vhq9Uxl4GT
November 30th 2022, 2:11am
HaltTrade @HaltTrade
$ESALY $BIIB Key News Update Eisai, Biogen Alzheimer's drug slows cognitive decline, safety for some becomes focus… https://t.co/9J9ZL4HeFs
November 30th 2022, 2:11am
YuZhu4 @YuZhu4
RT @JacobPlieth: Christopher van Dyck on the widening lecanemab effect in Clarity-AD $ESALY $BIIB #CTAD22 https://t.co/BxX64MPZDQ
November 30th 2022, 1:11am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.